Edwards Lifesciences Corporation Stock
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.49 USD | +0.41% |
|
-2.00% | +3.32% |
| 16/07 | Morgan Stanley Adjusts Price Target on Edwards Lifesciences to $81 From $75, Maintains Equalweight Rating | MT |
| 11/07 | Argus Initiates Edwards Lifesciences at Buy, $90 Price Target | MT |
| Capitalization | 44.87B 38.5B 35.87B 33.37B 61.57B 3,864B 68.75B 433B 164B 1,812B 168B 165B 6,660B | P/E ratio 2025 * |
31.6x | P/E ratio 2026 * | 28.4x |
|---|---|---|---|---|---|
| Enterprise value | 41.5B 35.61B 33.18B 30.87B 56.95B 3,574B 63.59B 401B 151B 1,676B 156B 152B 6,160B | EV / Sales 2025 * |
7.04x | EV / Sales 2026 * | 6.28x |
| Free-Float |
89.32% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Edwards Lifesciences Corporation
More recommendations
More press releases
| 1 day | +0.41% | ||
| 1 week | -2.00% | ||
| Current month | -2.20% | ||
| 1 month | +3.39% | ||
| 3 months | +6.93% | ||
| 6 months | +9.62% | ||
| Current year | +3.32% |
| 1 week | 75.3 |  | 78.8 |
| 1 month | 73.38 | | 78.9 |
| Current year | 65.94 | | 78.9 |
| 1 year | 58.93 | | 88.5 |
| 3 years | 58.93 | | 107.92 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 20.84 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 11/05/2023 | |
Scott Ullem
DFI | Director of Finance/CFO | 58 | 01/01/2014 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 61 | 10/02/2015 |
| Director/Board Member | 57 | 11/05/2023 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 2.46% | 45 M€ | -4.81% | - | |
| 2.34% | 21 M€ | +4.92% | - | |
| 1.17% | 25 M€ | -0.73% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.41% | -2.00% | -11.57% | -24.45% | 44.87B | ||
| +0.48% | +1.28% | +13.98% | +141.85% | 186B | ||
| -2.41% | -4.62% | -22.38% | -22.75% | 157B | ||
| -0.97% | +0.43% | +33.63% | +174.83% | 153B | ||
| -2.43% | -7.22% | -21.96% | -25.69% | 136B | ||
| -1.03% | +0.07% | -15.52% | -3.66% | 59.9B | ||
| +3.75% | +1.92% | -21.23% | -27.32% | 37.96B | ||
| +0.58% | +1.38% | +26.96% | +14.75% | 37.76B | ||
| -0.37% | +1.10% | -5.57% | - | 34.78B | ||
| -2.04% | -7.54% | -13.50% | -4.26% | 32.38B | ||
| Average | -0.40% | -1.33% | -3.72% | +24.81% | 87.94B | |
| Weighted average by Cap. | -0.82% | -1.70% | -0.69% | +52.31% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.9B 5.06B 4.71B 4.39B 8.09B 508B 9.03B 56.94B 21.5B 238B 22.12B 21.66B 875B | 6.46B 5.54B 5.16B 4.8B 8.86B 556B 9.9B 62.38B 23.55B 261B 24.23B 23.73B 959B |
| Net income | 1.42B 1.22B 1.14B 1.06B 1.95B 122B 2.18B 13.72B 5.18B 57.36B 5.33B 5.22B 211B | 1.58B 1.35B 1.26B 1.17B 2.17B 136B 2.42B 15.25B 5.76B 63.74B 5.92B 5.8B 234B |
| Net Debt | -3.37B -2.89B -2.69B -2.5B -4.62B -290B -5.16B -32.52B -12.28B -136B -12.63B -12.37B -500B | -4.31B -3.7B -3.45B -3.21B -5.92B -371B -6.6B -41.63B -15.71B -174B -16.17B -15.83B -640B |
More financial data
* Estimated data
Employees
15,800
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/07/25 | 76.49 $ | +0.41% | 4,816,621 |
| 17/07/25 | 76.18 $ | +0.05% | 4,140,711 |
| 16/07/25 | 76.14 $ | -0.87% | 5,066,793 |
| 15/07/25 | 76.81 $ | -1.88% | 3,990,873 |
| 14/07/25 | 78.28 $ | +0.29% | 4,845,131 |
Delayed Quote Nyse, 19 July 2025 at 06:00 am AEST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
76.49USD
Average target price
81.79USD
Spread / Average Target
+6.93%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition